Q.21 Junctional diversity of antibody molecules results from
(A) the addition of switch region nucleotides
(B) the addition of N and P nucleotides
(C) the joining of V, D and J segments
(D) mutations in complementarity-determining regions

Junctional Diversity in Antibody Molecules: MCQ Solved

Junctional diversity enhances antibody variability during V(D)J recombination in B cells. The correct answer is (B) the addition of N and P nucleotides.​

Option Analysis

Addition of switch region nucleotides (A): Switch regions drive class-switch recombination, altering antibody isotypes like IgM to IgG without affecting antigen specificity. This does not contribute to junctional diversity in variable regions.​

Addition of N and P nucleotides (B): Correct. N-nucleotides are randomly added by terminal deoxynucleotidyl transferase (TdT) at V-D and D-J junctions; P-nucleotides form from hairpin loops during imprecise joining. This creates frameshifts in CDR3, vastly increasing diversity.​

Joining of V, D, and J segments (C): This provides combinatorial diversity via segment selection, but junctional diversity specifically arises from nucleotide modifications at junctions.​

Mutations in complementarity-determining regions (D): Somatic hypermutation introduces point mutations post-antigen exposure for affinity maturation, not during initial junctional events.​

Junctional diversity of antibody molecules is a key mechanism in adaptive immunity, enabling vast antigen recognition. This process occurs at gene segment junctions during B-cell development, primarily through nucleotide additions that randomize CDR3 sequences.​

Mechanisms of Junctional Diversity

V(D)J recombination joins variable (V), diversity (D—for heavy chains), and joining (J) segments. Exonuclease nibbling removes nucleotides; TdT adds non-templated N-nucleotides (up to 20); P-nucleotides arise from hairpin resolution. These changes yield ~10^6-fold diversity amplification beyond combinatorial joining.​

• Exonuclease activity: Trims segment ends variably.

• P-addition: Palindromic sequences from loops.

• N-addition: Random, TdT-dependent in pro/pre-B cells.

Role in Antibody Production

Heavy chain CDR3, formed at V-D-J junctions, is longest and most diverse, shaping the antigen-binding pocket. Light chains use V-J only. This ensures polyclonal responses to pathogens.​

Clinical Relevance

Defects in TdT or RAG enzymes cause immunodeficiencies like SCID, reducing junctional diversity. Therapeutic antibodies exploit engineered diversity.​

This junctional diversity of antibody molecules underpins humoral immunity, critical for vaccines and autoimmunity research.​